Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Search
Sign in
Sign up
InfuSystem Holdings
INFU
Market cap
$186M
Overview
Fund Trends
Analyst Outlook
Journalist POV
9.18
USD
-0.11
1.18%
At close
Updated
Mar 3, 4:00 PM EST
Pre-market
After hours
1D
5D
1M
3M
6M
YTD
1Y
5Y
10Y
1 day
-1.18%
5 days
5.52%
1 month
10.74%
3 months
-1.71%
6 months
-12.99%
Year to date
9.42%
1 year
26.45%
5 years
-49.59%
10 years
179.88%
Upgrade to unlock
Positive
Neutral
Negative
Sentiment
3-Months
Positive
Neutral
66.7%
Negative
Positive
Neutral
Negative
Neutral
Seeking Alpha
7 days ago
InfuSystem Holdings, Inc. (INFU) Q4 2025 Earnings Call Transcript
InfuSystem Holdings, Inc. (INFU) Q4 2025 Earnings Call Transcript
Positive
Zacks Investment Research
7 days ago
InfuSystems Holdings, Inc. (INFU) Q4 Earnings Beat Estimates
InfuSystems Holdings, Inc. (INFU) came out with quarterly earnings of $0.1 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.04 per share a year ago.
Neutral
Business Wire
7 days ago
InfuSystem Announces Financial Results for Fourth Quarter and Full Year 2025
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Announces Financial Results for Fourth Quarter and Full Year 2025.
Neutral
Business Wire
14 days ago
InfuSystem to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026.
Positive
Seeking Alpha
1 month ago
InfuSystem: Regulatory Backed Market Catalyst
InfuSystem: Regulatory Backed Market Catalyst
Neutral
Business Wire
2 months ago
Ambulatory Infusion Pumps used in Pain Management Business by InfuSystem to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--Ambulatory Infusion Pumps used in Pain Management Business by InfuSystem to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026.
Positive
Seeking Alpha
3 months ago
InfuSystem Stock: Margin Expansion And Growth Strategy To Drive Strong Gains
InfuSystem Holdings offers strong growth potential and appears attractively valued after reporting positive Q3 2025 earnings results. INFU's Patient Services segment, especially oncology and wound care, is driving revenue growth, while Device Solutions faced a temporary decline. Margin improvements, new contracts, and the Apollo acquisition are enhancing profitability and expanding INFU's market share and efficiency.
Neutral
Business Wire
3 months ago
InfuSystem to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025.
Positive
Seeking Alpha
3 months ago
InfuSystem Set To Be A Cash Cow In 2026
InfuSystem (INFU) is prioritizing profitability and margin expansion under new CEO Carrie Lachance, shifting focus from unprofitable revenue streams. INFU's integration of Apollo Medical's billing system and new ERP is expected to drive significant operational efficiencies and margin gains in FY2026. Capital discipline enables INFU to repurchase shares and reduce debt, while growth opportunities in Wound Care and Oncology remain robust.
Positive
Zacks Investment Research
3 months ago
Wall Street Analysts Predict a 40% Upside in InfuSystems Holdings (INFU): Here's What You Should Know
The consensus price target hints at a 40% upside potential for InfuSystems Holdings (INFU). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Show more
See News Rankings
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Theme
Close